Skip to main content
OpenTrials
Completed

NCT Number: NCT04366024

A Novel Nomogram to Predict Severity of COVID-19

Investigators use clinical data from a large sample of COVID-19 disease patients to screen out biomarkers associated with disease severity. Then, a novel nomogram model will be established to predict covid-19 disease severity, which could provide important assistance and supplement for clinical work. In the case of extremely shortage of front-line medical resources, patients with potential severe diseases will be timely treated with the help of the novel nomogram model.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Disease Nomogram Model

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Xinqiao Hospital of Chongqing

Chongqing, Chongqing Municipality, 400000, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COVID-19 disease patients confirmed by virus nucleic acid RT-PCR and CT

Exclusion criteria

  • unconfirmed suspected cases
  • Patients during pregnancy and lactation
  • incomplete clinical data
  • investigators considered patients ineligible for the trial
  • Child patients

Treatment and study plan

other

Other

clinical diagnosis

Primary outcomes

  1. the consistency of predicted severe rate and observed severe rate of COVID-19 patients

    Time frame: up to 3 months

    We aim to use the clinical data of COVID-19 patients to construct a nomogram model to predict the severe rate of each patient, then the the consistency of predicted severe rate and observed severe rate will be evaluated by calibration plot.

  2. Duration of severe illness

    Time frame: up to 3 months

    the duration of severe illness of each patient will evaluated

Sponsors and collaborators

Lead sponsor

Xinqiao Hospital of Chongqing

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Apr 28, 2020
Registry last updated
Feb 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.